Amini Massoud, Safaei Hassan, Aminorroaya Ashraf
Isfahan Endocrine and Metabolism Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Rev Diabet Stud. 2007 Winter;4(4):242-8. doi: 10.1900/RDS.2007.4.242. Epub 2008 Feb 10.
The study was carried out to determine the five-year incidence of microalbuminuria and to assess its associated risk factors for type 2 diabetic patients in Isfahan, Iran.
505 type 2 diabetic patients (22% male, 78% female) with normal urinary albumin levels, being treated at Isfahan Endocrine and Metabolism Research Center, were consecutively selected. After the initial selection in 1999, the patients were followed for five years. Mean and standard deviation (SD) of age and duration of diabetes was 57.4 (9.5) and 10.2 (4.7) years, respectively. BMI, blood pressure, fasting plasma glucose, HbA1c, serum lipids and serum creatinine were measured and re-examined every three months. 24-h urinary albumin excretion was measured and reviewed annually. Microalbuminuria was diagnosed when at least two measurements indicated the excretion of more than 30 mg albumin in 24-h urinary samples.
During 5-year follow up, 176 patients developed microalbuminuria, giving an incidence rate of 82.3/1000 person/year (95% CI: 78.3-86.2). Males had a higher incidence than females (104.4 vs. 66.2/1000 person/year, p < 0.001). Duration of diabetes, abnormal levels of HbA1c, hypertension and high serum creatinine were significantly associated with microalbuminuria. There was no difference in mean of age, BMI, and lipid levels between patients with and without microalbuminuria. Multivariate analysis was used to show that duration of diabetes, HbA1c, hypertension and retinopathy were the independent variables related to microalbuminuria.
The incidence of microalbuminuria in the study population was higher than in other populations. The higher incidence and the considerable gender difference in this population may be attributed to inferior glycemic control and lack in screening for risk factors, but this needs to be explored in further studies.
开展本研究以确定伊朗伊斯法罕2型糖尿病患者微量白蛋白尿的五年发病率,并评估其相关危险因素。
连续选取在伊斯法罕内分泌与代谢研究中心接受治疗、尿白蛋白水平正常的505例2型糖尿病患者(男性22%,女性78%)。1999年进行初次筛选后,对患者进行了五年随访。年龄和糖尿病病程的均值及标准差分别为57.4(9.5)岁和10.2(4.7)年。每三个月测量并复查体重指数、血压、空腹血糖、糖化血红蛋白、血脂和血清肌酐。每年测量并复查24小时尿白蛋白排泄量。当至少两次测量表明24小时尿样中白蛋白排泄量超过30毫克时,诊断为微量白蛋白尿。
在5年随访期间,176例患者出现微量白蛋白尿,发病率为82.3/1000人/年(95%可信区间:78.3 - 86.2)。男性发病率高于女性(104.4对6&2/1000人/年,p<0.001)。糖尿病病程、糖化血红蛋白水平异常、高血压和高血清肌酐与微量白蛋白尿显著相关。有微量白蛋白尿和无微量白蛋白尿的患者在年龄均值、体重指数和血脂水平方面无差异。多变量分析表明,糖尿病病程、糖化血红蛋白、高血压和视网膜病变是与微量白蛋白尿相关的独立变量。
研究人群中微量白蛋白尿的发病率高于其他人群。该人群中较高的发病率和显著的性别差异可能归因于血糖控制不佳和缺乏危险因素筛查,但这需要在进一步研究中加以探讨。